Ascentage Pharma Group International Revenue Growth & History (AAPG)

Ascentage Pharma Group International reported ¥980.6M in revenue for fiscal 2024, an increase of 341.77% from the previous fiscal year.

View full Ascentage Pharma Group International company overview

Ascentage Pharma Group International annual revenue and growth

Ascentage Pharma Group International annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20242024-12-31¥980.6M¥758.7M+341.77%
20232023-12-31¥222.0M¥12.3M+5.85%
20222022-12-31¥209.7M
About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Primary source

SEC company filings

TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.

Review Ascentage Pharma Group International filings at SEC.gov ↗